DENTSPLY Sirona Inc

DENTSPLY Sirona Inc

XRAY

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.1B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
DENTSPLY Sirona IncDENTSPLY Sirona Inc-3.36.11%-48%0.51.8
$17.00

Target Price by Analysts

76.3% upsideDENTSPLY Sirona Target Price DetailsTarget Price
$19.37

Current Fair Value

100.9% upside

Undervalued by 100.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.10 Billion
Enterprise Value$4.27 Billion
Dividend Yield$0.48 (6.11%)
Earnings per Share$-3
Beta0.94
Outstanding Shares199,900,000

Return

Return on Equity-47.57%ROE
Return on Assets-11.99%
Return on Invested Capital-5.62%

Valuation & Multiples

P/E Ratio-3.33P/E Ratio
PEG2.22PEG
Price to Sales0.54Price to Sales
Price to Book Ratio1.61Price to Book Ratio
Enterprise Value to Revenue1.16
Enterprise Value to EBIT-18.89
Enterprise Value to Net Income-7
Total Debt to Enterprise0.55
Debt to Equity1.79Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 14, 2026
EPS Estimate
$0.29
Average shareholder expectation
Revenue Estimate
$842.58 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 6, 2026
EPS Estimate
$0.36
Average shareholder expectation
Revenue Estimate
$888.91 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.6619 37.70%
Total Calls869,500 66.60%
Total Puts575,500 6.14%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %106.49% 6.04%
Total Invested$2.46B 7.50%
Investors Holding392 25.00%

ESG Score

No data

About DENTSPLY Sirona Inc

CEO: Bret Wise

Relevant Senate Committees

Joint Committee on Taxation

This committee provides the technical analysis and official revenue estimates for all tax legislation. Its work directly influences the details of tax policy, which can have significant financial implications for DENTSPLY Sirona's corporate tax burden, capital investment credits, and overall profitability.

Finance

This powerful committee controls taxation, trade, and entitlement spending (e.g., Medicare, Medicaid). Changes in tax policy directly impact DENTSPLY Sirona's profitability, trade policy affects its global supply chain and sales, and entitlement spending policies can influence the demand for dental services.

Appropriations

This committee allocates discretionary federal spending. Its subcommittees determine the budgets for agencies like the VA, FDA, and NIH, which directly impacts funding for dental care programs, regulatory oversight, and research, all affecting DENTSPLY Sirona's market and regulatory environment.

Health, Education, Labor, and Pensions

This committee directly regulates the FDA, which is the primary regulatory body for medical devices, including dental equipment. Its oversight of NIH funding also impacts dental research, and labor laws affect manufacturing operations and costs.

Judiciary

This committee oversees antitrust laws and intellectual property (IP). IP protection is crucial for medical device manufacturers like DENTSPLY Sirona, and antitrust enforcement can impact mergers, acquisitions, and competitive practices within the industry.

Veterans' Affairs

The Department of Veterans Affairs is a major provider of healthcare services, including dental care, to veterans. Committee funding decisions directly impact the VA's budget for medical devices and supplies, which could include DENTSPLY Sirona products.